Our Research Results

Since we first began more than 40 years ago, Breast Cancer Trials (BCT) has contributed to more than 1,200 peer-reviewed publications and many of these research results have changed practice in the treatment and prevention of breast cancer.

The publication of the results of clinical trials research in a scientific journal or a periodic publication:

  • Fulfils the researchers’ ethical obligations to research participants and the general community;
  • Contributes to medical knowledge so doctors can make scientifically valid assessments of the benefits and risks of a new medicine or treatment for their patients.

BCT publishes study results in accordance with the BCT Publication Policy.

The citations for all of these publications are listed below, ordered by year. To search for a citation, enter a keyword/s and click search. Enclose multiple words in quotes “” to search for an exact match. Alternatively, you can search for clinical trials in a given year or for a particular clinical trial name. 

The majority of the publications can be accessed via PubMed, other research databases or publication storage systems at a university library (if you are a student/member), or directly to the journal or publication online. Many scientific journals provide articles as “open access”; however some require a subscription.

Become a Member

Are you actively involved in the conduct of breast cancer clinical trials research? Become a member today!

Become a Member

PUBLICATIONS

2024

Analysis of the sensitivity to endocrine therapy (SET) assay in the PALLAS adjuvant trial of palbociclib in HR+/HER2- breast cancer (ABCSG-42/AFT-05/BIG-14-13).

Metzger O, Ballman KV, Gnant M, Watson M, Chen E, Tran K, O’Brien P, Hlauschek D, Martin M, Balko JM, sowecki Z, Hahn OM, Denkert C, Curtis C, Liu Y, Dueck AC, Fesl C, Mayer EL, DeMichele A, Symmans WF. Journal of Clinical Oncology 2024; 42(suppl 16).:ASCO 2024, 538; 10.1200/JCO.2024.42.16_suppl.538, Abstract

Relationship of adaptive subtyping and tumour heterogeneity of treatment response to neoadjuvant therapy in hormone receptor–positive HER2-negative early breast cancer: PENELOPE-B.

Denkert C, Rachakonda K, Filipits M, Weber K, Marme f, Untch M, Witkeiwicz AK, Im S-A, DeMichele A, Pehl A, van’t Veer L, Jank P, Schem C, Fasching PA, Reimer T, Knudsen ES, Liu Y, Rojo Todo FG, Turner NC, Loibl S. Journal of Clinical Oncology. 2024; 42(suppl. 16).:566; 10.1200/JCO.2024.42.16_suppl.566, Abstract

Phase II study of neoadjuvant ipilimumab and nivolumab in combination with paclitaxel following anthracycline-based chemotherapy in patients with treatment resistant stage III triple negative breast cancer (TNBC): BCT1702—Survival results.

Loi S, Francis PA, Zdenkowski N, Gebski V, Fox SB, White M, Kiely BE, Hui R, Redfern AD, Calvert R, Rennie L, Badger H, Boyle FM. Journal of Clinical Oncology. 2024; 42(suppl 16).:608 [ASCO 2024]; 10.1200/JCO.2024.42.16_suppl.608, Abstract

Multiplexed high-thoroughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00.

Rusakiewicz S, Tyekucheva S, Tissot-Renaud S, Chaba K, Imbimbo M, Benedetti F, Kammler R, Hornfeld J, Munzone E, Gianni L, Thuerlimann B, Pruneri G, Gray K, Lang I, Regan MR, Loi S, Colleoni M, Viale G, Kandalaft L, Coukos G, Curigliano G. European Journal of Cancer. 2024; 200113535, doi: 10.1016/j.ejca.2024.113535. Epub 2024 Jan 24., E-pub

Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer.

Ganz PA, Bandos H, Spanic T, Friedman S, Muller V, Kuemmel S, Delaloge S, Brain E, Toi M, Yamauchi H, de Duenas E-M, Armstrong A, Im S-A, Song C, Zheng H, Sarsiek T, Sharma P, Geng C, Fu P, Rhiem K, Frachiger-Heuer H, Wimberger P, d’Kind de Roodenbeke D, Liao N, Goodwin A, Chakiba-Brugere C, Friedlander M, Lee KS, Giacchetti S, Takano T, Henao-Carrasco F, Virani S, Valdes-Albini F, Domchek SM, Bane C, McCarron EC, Mita M, Rossi G, Rastogi P, Fielding A, Gelber RD, et al. Journal of Clinical Oncology. 2024; 42(11):1288-1300, DOI https://doi.org/10.1200/JCO.23.01214, E-pub

Quality of life outcomes associated with optimization of treatment by omitting radiotherapy in early breast cancer.

Stafford L, Sinclair M, Butow P, Hughes J, Park A, Gilham L, Rose A, Mann GB. Clinical Breast Cancer. 2024; 1-10, ttps://doi.org/10.1016/j.clbc.2024.03.002, E-pub

Load more

Total Publications: 1314